USSTOCK.TODAY
Market Closed
Log in Sign up

Alaunos Therapeutics Inc(TCRT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

TCRT
TCRT
Alaunos Therapeutics Inc
At close Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$1.59
-0.13 ▼ -7.56%
Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$1.59
+0.00 +0.00%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -1.71Insider Own ⓘ 20.56%Shs Outstand ⓘ 4.2MPerf Week ⓘ -1.85%
Market Cap ⓘ 0.01BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 3.3MPerf Month ⓘ -48.38%
Enterprise Value ⓘ 0.01BPEG ⓘ -EPS next Q ⓘ -2.05Inst Own ⓘ 24.45%Short Float ⓘ 5.52%Perf Quarter ⓘ -9.66%
Income ⓘ -0.00BP/S ⓘ -EPS this Y ⓘ -Inst Trans ⓘ -0.47%Short Ratio ⓘ 0.02Perf Half Y ⓘ -32.91%
Sales ⓘ 0.00BP/B ⓘ 5.44EPS next 5Y ⓘ -ROA ⓘ -128.43%Short Interest ⓘ 0.18MPerf YTD ⓘ -50.77%
Book/sh ⓘ 0.29P/C ⓘ 10.97EPS past 3/5Y ⓘ 56.15% 47.89%ROE ⓘ -192%52W High ⓘ -64.67% ($4.50)Perf Year ⓘ -51.96%
Cash/sh ⓘ 0.14P/FCF ⓘ -Sales past 3/5Y ⓘ -88.04% -ROIC ⓘ -373.12%52W Low ⓘ 121.14% ($0.72)Perf 3Y ⓘ -84.27%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 26.04%Gross Margin ⓘ -966.67%Volatility(W/M) ⓘ 8.03% 11.37%Perf 5Y ⓘ -99.26%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -50%Oper. Margin ⓘ -121033.33%ATR (14) ⓘ 0.26Perf 10Y ⓘ -99.83%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 1.14EPS Q/Q ⓘ 43.48%Profit Margin ⓘ -129666.67%RSI (14) ⓘ 44.38Recom ⓘ 2.33
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 1.14Sales Q/Q ⓘ -SMA20 ⓘ -12.25% ($1.81)Beta ⓘ -0.97Target Price ⓘ $3.5
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ 2026/08/18SMA50 ⓘ -3.47% ($1.65)Rel Volume ⓘ 0.01Prev Close ⓘ $1.72
Employees ⓘ 1LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -29.46% ($2.25)Avg Volume(3M) ⓘ 7.44MPrice ⓘ $1.59
IPO ⓘ 2005/8/22Option/Short ⓘ No/YesTrades ⓘ 578Volume ⓘ 91,015Change ⓘ -7.56%
Company
TCRT TCRTAlaunos Therapeutics Inc | NASD | Biotechnology Deep dive

🧬 Alaunos Therapeutics () is a clinical-stage oncology cell therapy company headquartered in Houston, USA. It develops patient-specific TCR-T (T-cell receptor) cell therapies using its proprietary non-viral Sleeping Beauty gene insertion technology and is a micro-cap biotech stock that has recently been expanding its pipeline into areas such as obesity treatments.

Quote

Over the past 1 year, on the lower side

65% below its 1-year high.

Now $1.59
52w low$0.7252w high$4.50
52W Range23%
Volume ⓘ 91,015

Traded less than usual. That is 1% of its average volume.

C
Overall · average, with some caution
We judged 4 of the 8 questions below. 1 rate excellent and 2 need caution.
No data for growth, valuation, outlook, dividends, or not applicable.
ETFs holding this stock 1 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #523 of 598 in the industry

Based on market cap of $7M.

FAQ

FAQ

What kind of company is TCRT?

TCRT belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of TCRT?

The market cap of TCRT is approximately $7M, ranking 5,482 within its sector.

What is the 52-week high and low for TCRT?

TCRT has recorded a 52-week high of $4.50 and a low of $0.72.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels